27 Jun, 2013
ITC Sheraton Hotel, New Delhi
Home >> InDepth >>
Thursday, November 8, 2012 - 15:38 IST
The hazards of FDI in pharma biz in India
BY Raj Ramachandran & Manav Raheja
The challenge for foreign investors and Indian promoters is to determine whether and how to structure investment terms in order to comply with new conditions, without diluting their commercial considerations.
It’s not every day that a movie star appears before a parliamentary committee to debate on the issue of regulating foreign direct investment into the country. And if that movie star happens to be Aamir Khan,... To continue reading this article, you must be a Premium subscriber... A Premium membership gives you:
JOBS
- Private Equity - Nereus Capital
- Associate - Red Fort Capital Advisors Pvt Ltd
RECENT COMMENTS
- 19 June 2013RaxitonVrishank, gr8 interview, met shailesh few months back and really impressed!
- 18 June 2013Vijay SambamurthionWith all due respect.....I disagree with most of this article! The author has cleverly employed rhetoric to make a...
- 18 June 2013ManishonSandeep, your article does not provide any substantial reasons on why marketplace is more difficult than inventory-led...
- 17 June 2013rj.sridhar@gmail.comonI think it's a bit of a chicken & egg. Is it the combination of some shady promoters plus lack of enough exits...
UPCOMING EVENTSchinetwork